Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	Andalusian Health Technology Assessment Area (AETSA)	[Eculizumab (Soliris®) Assessment of effectivity and safety of the drug and economic analysis of use in Paroxysmal Nocturnal Haemoglobinuria therapy]
2011	Health Services Assessment Collaboration (HSAC)	Systematic review of systems of palliative care
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pre-operative skin preparation solutions: a review of the evidence on safety
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Total hip and knee artroplasties in Catalonia. Effectiveness and safety]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	MAKO's RESTORIS implants and MAKOplasty procedure for early to mid-stage osteoarthritic knee disease: a review of the clinical and cost-effectiveness and safety
2011	Agency for Healthcare Research and Quality (AHRQ)	Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Blood pressure monitoring chairs to identify hypertension: a review of the clinical effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interferon-gamma release assays testing versus tuberculosis skin testing for tuberculosis: a review of the clinical effectiveness and guidelines
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Point of care cholesterol testing for coronary heart disease: a review of the clinical effectiveness and guidelines
2011	HAYES, Inc.	Acupuncture for Assisted Reproduction
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Disposable gloves for use in healthcare settings: a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
2011	HAYES, Inc.	Dentatorubral-Pallidoluysian Atrophy (DRPLA)
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personal]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mycophenolate mofetil tablets for uveitis: a review of the comparative clinical and cost-effectiveness
2011	HAYES, Inc.	Botulinum toxin treatment for migraine headache
2011	Adelaide Health Technology Assessment (AHTA)	Review of MBS items for specific ophthalmology services under the MBS Quality Framework (Stage I)
2011	Medical Advisory Secretariat (MAS)	Emerging pharmacogenomic tests
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis: a review of the clinical evidence
2011	HAYES, Inc.	Capsule endoscopy for the diagnosis of small bowel disease in children
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Gefitinib (Iressa®) for the 1st-line treatment of non-small cell lung cancer
2011	Adelaide Health Technology Assessment (AHTA)	Review of interim funded service: vertebroplasty and new review of kyphoplasty
2011	NIHR Health Technology Assessment programme	A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET)
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and assessment tools for patients with chronic disease in therapeutic exercise program: a review of the clinical evidence and guidelines
2011	HAYES, Inc.	Catheter-directed thrombolysis for acute peripheral arterial occlusion
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Parenteral versus oral methotrexate for the treatment of rheumatoid arthritis: a review of the clinical evidence
2011	HAYES, Inc.	Catheter-directed thrombolysis for deep vein thrombosis
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2011	HAYES, Inc.	Computer-aided diagnosis (CADx) systems for breast ultrasonography: cancer detection and diagnosis
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	[Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011	Blue Cross Blue Shield Association (BCBS)	Cardiac resynchronization therapy for mild heart failure
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Central monitors for acutely-ill cardiac patients in a small, rural hospital setting: a review of clinical and cost-effectiveness
2011	HAYES, Inc.	Computer-aided diagnosis (CADx) systems for breast ultrasonography: classification of masses
2011	Andalusian Health Technology Assessment Area (AETSA)	[Biological therapies in the treatment of rheumatoid arthritis]
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Panitumumab (Vectibix®) as 1st-line combination therapy for the treatment of WT KRAS colorectal cancer – 1st Update 2011
2011	Institute for Clinical Evaluative Sciences (ICES)	Geographic access to primary care and hospital services for rural and northern communities: report to the Ontario Ministry of Health and Long-Term Care
2011	Blue Cross Blue Shield Association (BCBS)	Fractional flow reserve and coronary artery revascularization
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines for children, adolescents and adults with ADHD
2011	HAYES, Inc.	Continuous passive motion for the treatment of joint contractures of the extremities
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Abraxane for malignant melanoma – first line
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Everolimus (Afinitor) for the treatment of renal cell carcinoma]
2011	Blue Cross Blue Shield Association (BCBS)	Computed tomographic coronary angiography in the evaluation of patients with acute chest pain
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines
2011	HAYES, Inc.	Diaphragmatic/phrenic nerve stimulation
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy
2011	Andalusian Health Technology Assessment Area (AETSA)	[Prenatal screening for aneuploidy using free fetal DNA in maternal blood. Systematic review of the literature.]
2011	NIHR Health Technology Assessment programme	Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
2011	Blue Cross Blue Shield Association (BCBS)	Special report: maintenance therapy in advanced non-small-cell lung cancer
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
2011	HAYES, Inc.	Endoscopic ultrasound (EUS) for diagnosis of pancreatic tumors
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Bevacizumab (Avastin) with octreotide (Sandostatin) for high risk carcinoid tumours – first or second line
2011	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of active immunotherapy in HIV-infected adults. Therapeutic vaccines against HIV.]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Lapatinib (Tyverb) for the treatment of metastatic breast cancer]
2011	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	MALDI-TOF mass spectrometry for bacterial species identification: a review of diagnostic accuracy and clinical and cost-effectiveness
2011	HAYES, Inc.	Endoscopic ultrasound (EUS) for locoregional staging of pancreatic tumors
2011	Andalusian Health Technology Assessment Area (AETSA)	[Use of QALYs in different clinical situations]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Ofatumumab (Arzerra®) for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab]
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ventilation/perfusion scintigraphy (using Technegas) versus computed tomography pulmonary angiography for the diagnosis of pulmonary embolism in hospitalized patients: a review of the clinical and cost-effectiveness
2011	HAYES, Inc.	Endoscopic ultrasound-guided fine needle aspiration biopsy (EUS-FNA) for diagnosis of pancreatic cancer
2011	Andalusian Health Technology Assessment Area (AETSA)	[Impella Recover® 2.5 ventricular assist device]
2011	Penn Medicine Center for Evidence-based Practice (CEP)	Celecoxib for pain control in joint arthroplasty
2011	HAYES, Inc.	High-frequency chest wall compression for diseases other than cystic fibrosis
2011	Andalusian Health Technology Assessment Area (AETSA)	[Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011	Medical Advisory Secretariat (MAS)	Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis
2011	HAYES, Inc.	Intranasal trivalent live attenuated influenza vaccine
2011	Health Information and Quality Authority (HIQA)	A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
2011	Penn Medicine Center for Evidence-based Practice (CEP)	Argon plasma coagulation for surgical procedures
2011	National Institute for Health and Care Excellence (NICE)	Golimumab for the treatment of psoriatic arthritis. NICE technology appraisal guidance 220
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Tolvaptan (Samsca) for the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion]
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Computerised cognitive behavioural therapy for adults with depression
2011	HAYES, Inc.	Mechanical stretching devices for the treatment of joint contractures of the extremities
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2011	HAYES, Inc.	testing
2011	National Institute for Health and Care Excellence (NICE)	Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia. NICE technology appraisal guidance 218
2011	Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)	Transnasal oesophagoscopy (TNE)
2011	HAYES, Inc.	Nerve blocks for the treatment of chronic nonmalignant pain
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Brivanib for hepatocellular carcinoma – second line
2011	HAYES, Inc.	title
2011	National Institute for Health and Care Excellence (NICE)	Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 214
2011	HAYES, Inc.	Neuronavigation for intracranial biopsy and intracranial surgery
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2011	National Institute for Health and Care Excellence (NICE)	Bendamustine for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 216
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Enzymatic replacement treatment for type I gaucher's disease patients]
2011	HAYES, Inc.	Positron Emission Tomography (PET) and combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and initial staging of ovarian cancer
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011	National Institute for Health and Care Excellence (NICE)	Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years. NICE technology appraisal guidance 213
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Literature review of organisational and patient aspects in HTA]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2011	Medical Advisory Secretariat (MAS)	Continuous glucose monitoring for patients with diabetes
2011	HAYES, Inc.	Progesterone for the prevention of preterm birth
2011	NIHR Horizon Scanning Centre (NIHR HSC)	EC145 for folate receptor positive ovarian cancer
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of urea breath test for helicobacter pylori detection]
2011	HAYES, Inc.	Recombinant human bone morphogenetic protein for use in spinal fusion
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011	Health Information and Quality Authority (HIQA)	Health technology assessment of robot-assisted surgery in selected surgical procedures
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nucleoplasty for patients with discogenic back pain]
2011	HAYES, Inc.	Recombinant human bone morphogenetic protein for use in tibia repair
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of the bilateral cochlear implant in children]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients with stroke or brain trauma]